The first two vaccines (both messenger ribonucleic acid — mRNA — vaccines) for the prevention of COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been authorized for emergency use. People with cancer are at a higher risk for serious illness resulting from COVID-19, but were not specifically included in the trials that assessed the safety of the mRNA vaccines. It is uncertain whether it is recommended or safe for this population to be among the first groups of people who get vaccinated. Some countries, but not Canada at the time of this report, have included people with cancer as part of the groups being considered for priority access to COVID-19 vaccines. Further study and information-gathering are still required.
Link to Report
Provide Feedback
Was this site helpful?
If you couldn’t find what you are looking for, please submit a request.